Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So??? what s your point? and by the way, nobody have been found guilty of anything!!!
Still 33% UP SINCE !!!
And 75% UP SINCE !!!
...
and it will go back down and back up and back down and back up...
nop, to give a Number, This One:
The new North American number is: 1-646-770-3829
...!
Of course it have a purpose!!
TO GIVE THE NEW NUMBER !!
...
I think you should Read post num 884 Kid!!!!
what are you talking about???
??? what are all those 5000???
yea, it s the last day to cover, they have till monday...
WOW, so now Lapresse knows better then the SEC.
PPPFFFFFFFFFFFFFFFFF!!!
exactly, sound like a kind of 'take over' of some sort to me. Can only be for the best... specialty coming from the people who have a big contract with the Corp!!
...
CREDO-TM is now PROVEN to be a REAL COMPANY!!
thank you
LOL
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=61543757
so what!!!! it s been a long time it s like that, Claude isnt even mension there...
pffff
Nop, RUSTERN YUSUPOV, new Vice President MArketing of MRES and President of Credo-TM...
lol
what are you talking about www.google.ca/search?q=kazan+russia&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a
what doesnt exist ????
pfff
1st, the president of Credo-TM, Mr Rustern Yusupov, will assume the position of Vice-President Marketing,
second, MRES meet the Deputy Minister of the Russian Federation
and now, Mr Rustern is putting out the PR from Kazan,
ALL THIS IS STARTING TO SMELL VERY VERY GOOD !!!
Indeed, and it s comming out of Kazan!! From the Russian Federation...!!!
I Have a very good feeling
Sorry, but you where saying ???
lol
what do you mean? not sure I get you !
I did some time ago via this email: info@neuro-agora.com
and got an answer 2 or 3 days later...
Indeed, that s a MASSIVE Form T Buy !!!
WOW, lets see what this Baby will bring us tomorrow!!!
GTLA and good evening all
NO NO , Sounds like they DONT WANT to loose control, since they are CONTROLLING shareholders !!!!
pfffff
hey maybe the major controlling shareholder dont want to give 100 of the corp like Auric wishes they could have. But after DD and talkings and negotiations they agreed on 25% so 150 000 000 shares and a private placement to cover the rest they wanted to have...
simple as 1 2 3 ...
So what, with one transaction of 8$ !!!!
who cares it s like nothing happened!!!!
LOLOLOL
NEWZ OUT!!!! Updates on Due Diligence
Neuro-Biotech Corp. (PINKSHEET: MRES) (OTCQB: MRES) is pleased to provide its shareholders updates about the due diligence process and the conditions of the unsolicited offer. As of Friday February 25, all the conditions required by the parties in order to complete their due diligence have been met:
* AURIC Pharma Science has provided financial statements proving its ability to complete the purchase.
* AURIC Pharma Science has provided detailed distribution network of its products and services.
* Neuro-Biotech Corp.has provided patent information on all its exclusive products and services.
* Neuro-Biotech Corp. has provided all previous and effected purchase orders, as well as future pending orders.
Neuro-Biotech management has decided to publish some of this information directly on its website in order for the shareholder to access it easily.
Management would also like to announce that management is expecting to complete it's diligence process by the end of the day on March 4, 2011.
For more information on Neuro-Biotech Corp or to contact a company representative, please visit: www.neuro-biotechcorp.com
FORWARD LOOKING STATEMENTS
This release contains statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "expects," "intends," "may," "projects," "targets" and other similar language that is considered forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties and persons reading this release are cautioned that such statements are only predictions, and that the Company's actual future results or performance may be materially different. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events, or otherwise, could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
SOURCE Neuro-Biotech Corp.
yea your right, but ether way they never said they will release a PR today, only that they Should be getting some info today...no?
Not at all, they said that the outstanding conditions that have yet to be met in order to complete the due diligence will be addressed to the Corp by the end of Feb 25, so before 23h59 basically...
Such details should be addressed by end of the day, on February 25, 2011.
http://ih.advfn.com/p.php?pid=nmona&article=46481886
My guess is that they will release a PR about it on Monday!!!
it s no longer the Barter Bank, it is Cloud Computing Software now!!
( well it s basically the software built for the Barter Bank )
NEWS OUT
Neuro-Biotech Corp.: Conditions of Unsolicited Offer
Neuro-Biotech Corp (USOTC:MRES)
Intraday Stock Chart
Today : Wednesday 16 February 2011
Click Here for more Neuro-Biotech Corp Charts.
Neuro-Biotech Corp.: Conditions of Unsolicited Offer
PR Newswire
BASEL, Switzerland, Feb. 16
BASEL, Switzerland, Feb. 16 /PRNewswire/ - Neuro-Biotech Corp. (PINKSHEET: MRES) (OTCQB: MRES) is pleased to provide its shareholders additional details about the unsolicited offer. The conditions to be met are as follows:
1. AURIC Pharma Science will provide financial statements proving its ability to complete the purchase.
2. AURIC Pharma Science will provide detailed distribution network of its products and services.
3. Neuro-Biotech Corp. will provide patent information on all its exclusive products and services.
4. Neuro-Biotech Corp. will provide all previous and effected purchase orders, as well as future pending orders.
Both companies will also be signing a Non-Disclosure Agreement for certain areas of their due diligence but Neuro-Biotech Corp. intends on disclosing all possible information to its shareholders along the process.
For more information on Neuro-Biotech Corp or to contact a company representative, please visit: www.neuro-biotechcorp.com
FORWARD LOOKING STATEMENTS
This release contains statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "expects," "intends," "may," "projects," "targets" and other similar language that is considered forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties and persons reading this release are cautioned that such statements are only predictions, and that the Company's actual future results or performance may be materially different. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events, or otherwise, could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
SOURCE Neuro-Biotech Corp.
indeed, that is just a little normal transaction to them lol!!
Here they post a Auric profile on their website
http://neuro-biotechcorp.com/applications/neuro-biotechcorp.com/groupware/files/personal/1/About_Auric_Pharma_Science.pdf
THE BOARD OF DIRECTORS ACCEPTED THE 15 CENT OFFER
Neuro-Biotech Corp (USOTC:MRES)
Intraday Stock Chart
Today : Tuesday 15 February 2011
Click Here for more Neuro-Biotech Corp Charts.
Neuro-Biotech Corp. (PINKSHEET: MRES) (OTCQB: MRES). Dr. Claude Poulin CEO is pleased to announce to its shareholders that the board of directors have voted to accept the 15 cent offer. Full details will be provided to shareholders at closing of market February 15, 2011.
For more information on Neuro-Biotech Corp or to contact a company representative, please visit: www.neuro-biotechcorp.com
FORWARD LOOKING STATEMENTS
This release contains statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "expects," "intends," "may," "projects," "targets" and other similar language that is considered forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties and persons reading this release are cautioned that such statements are only predictions, and that the Company's actual future results or performance may be materially different. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events, or otherwise, could cause the company's actual results to differ materially from those indicated in any forward-looking statements. Neuro-Biotech Corp. Dr. Claude Poulin 41 61 500 05 16 info@neuro-agora.com www.neuro-biotechcorp.com
SOURCE Neuro-Biotech Corp.
YES NEWS OUUUUTTT!!!!!
Neuro-Biotech Corp: THE BOARD OF DIRECTORS ACCEPTED THE 15 CENT OFFER
Neuro-Biotech Corp (USOTC:MRES)
Intraday Stock Chart
Today : Tuesday 15 February 2011
Click Here for more Neuro-Biotech Corp Charts.
Neuro-Biotech Corp. (PINKSHEET: MRES) (OTCQB: MRES). Dr. Claude Poulin CEO is pleased to announce to its shareholders that the board of directors have voted to accept the 15 cent offer. Full details will be provided to shareholders at closing of market February 15, 2011.
For more information on Neuro-Biotech Corp or to contact a company representative, please visit: www.neuro-biotechcorp.com
FORWARD LOOKING STATEMENTS
This release contains statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "expects," "intends," "may," "projects," "targets" and other similar language that is considered forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties and persons reading this release are cautioned that such statements are only predictions, and that the Company's actual future results or performance may be materially different. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events, or otherwise, could cause the company's actual results to differ materially from those indicated in any forward-looking statements. Neuro-Biotech Corp. Dr. Claude Poulin 41 61 500 05 16 info@neuro-agora.com www.neuro-biotechcorp.com
SOURCE Neuro-Biotech Corp.
hehe thank you, i think it showed a good ''over-all profile'' of MRES
very encouraging for the future in my book
well you cant say that right now, we need to wait for them to gives us more detail like they stated they will after doing some DD... and if they do well alright if they dont oh oh!!
WOW 8 cents on the PreMarket!!! i got waken up by my broker lol!!
GO BABY MRES GO!!!
haha yup, a 369 350 Form T BUY at 16:02 !!!
MRES IS UP !! Damn Market Fluctuations !!!
lolol
WEEEEEEE UMNG UP 50% !!!